This market has settled: RESOLVED
Settled on March 24, 2026
Will Joel Embiid lead the NBA in points during the 2025–26 NBA season?
Will Joel Embiid lead the NBA in points during the 2025–26 NBA season? Odds: 0.1% YES on Polymarket. See live prices and trade this market.
Joel Embiid 2025-26 Scoring Title Analysis
Current Odds
| Platform | Yes | No | Volume | Trade |
|---|---|---|---|---|
| Polymarket | 0.1% | 99.9% | $10K | Trade on Polymarket |
Market Analysis
At 0.1% odds, the market is essentially pricing out Embiid’s chances of leading the league in scoring, reflecting legitimate structural concerns about his injury history and the competitive landscape he’ll face. This valuation matters because it represents peak pessimism—any material shift in his health status or roster composition could dramatically reprrice this contract before the 2025-26 season tips off in October 2025.
The bull case hinges on Embiid’s elite scoring talent and Philadelphia’s likely offensive architecture around him. When healthy, he averages 33+ points per game and remains the NBA’s most dominant low-post scorer; if the 76ers construct their roster to maximize his usage without significant roster turnover, he enters the season as a legitimate contender. The catalyst to watch is the 76ers’ roster construction this offseason and Embiid’s conditioning reports during preseason (September-October 2025). Any evidence of full health recovery from his 2024-25 season injuries, combined with reduced defensive load or load management, would compress these odds significantly.
The bear case is more compelling: Embiid has missed 50+ games in three of the last four seasons, and the league’s scoring title typically goes to volume scorers who stay on the court. Luka Doncic, Shai Gilgeous-Alexander, and potentially Jayson Tatum are more durable alternatives with similar offensive capabilities. Even if Embiid plays 70+ games—an optimistic scenario—his lower game frequency relative to competitors makes the title statistically unlikely. The 76ers have also shown willingness to rest him strategically, which directly undermines scoring title odds.
The market is essentially betting against Embiid’s availability and durability rather than his ceiling talent. Traders should monitor his playoff performance in April-May 2025, his offseason training reports (July-August 2025), and any front office statements about usage philosophy before next season. If he plays 75+ games in 2024-25 without setbacks, these odds could spike to 1-2% range; conversely, any significant injury setback would cement the 0.1% valuation as fair.
Related Markets
- Will the Phoenix Suns win the 2026 NBA Finals? — 1% YES
- Will the Miami Heat win the 2026 NBA Finals? — 1% YES
- Will Qatar win the 2026 FIFA World Cup? — 0% YES
Frequently Asked Questions
What specific injury concerns are priced into these odds?
The market reflects Embiid’s chronic knee and foot issues—he’s played 51, 56, and 39 games respectively over the last three seasons. Even one significant absence in 2025-26 would likely eliminate his scoring title candidacy.
How does the 76ers’ potential Evan Turner contract situation affect this market?
If Philadelphia makes major roster changes that reduce Embiid’s usage rate (e.g., acquiring another alpha scorer), his scoring title probability drops further, though this scenario seems unlikely given their current trajectory.
Would winning the MVP award in 2024-25 increase these odds heading into 2025-26?
Marginally—it would signal improved health durability, but scoring titles specifically reward volume and consistency, not accolades. Embiid would need 72+ games played in back-to-back seasons to become a realistic contender.